These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 37768718)

  • 1. Monomeric agonist peptide/MHCII complexes activate T-cells in an autonomous fashion.
    Platzer R; Hellmeier J; Göhring J; Perez ID; Schatzlmaier P; Bodner C; Focke-Tejkl M; Schütz GJ; Sevcsik E; Stockinger H; Brameshuber M; Huppa JB
    EMBO Rep; 2023 Nov; 24(11):e57842. PubMed ID: 37768718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting CD4 T-cell epitopes based on antigen cleavage, MHCII presentation, and TCR recognition.
    Schneidman-Duhovny D; Khuri N; Dong GQ; Winter MB; Shifrut E; Friedman N; Craik CS; Pratt KP; Paz P; Aswad F; Sali A
    PLoS One; 2018; 13(11):e0206654. PubMed ID: 30399156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cloned T cells internalize peptide from bound complexes of peptide and purified class II major histocompatibility complex antigen.
    Nag B; Deshpande SV; Sharma SD; Clark BR
    J Biol Chem; 1993 Jul; 268(19):14360-6. PubMed ID: 7686154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of peptide binding patterns in different major histocompatibility complex/T cell receptor complexes using pigeon cytochrome c-specific T cell hybridomas. Evidence that a single peptide binds major histocompatibility complex in different conformations.
    Bhayani H; Paterson Y
    J Exp Med; 1989 Nov; 170(5):1609-25. PubMed ID: 2553848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The MHC class II ligand lymphocyte activation gene-3 is co-distributed with CD8 and CD3-TCR molecules after their engagement by mAb or peptide-MHC class I complexes.
    Hannier S; Triebel F
    Int Immunol; 1999 Nov; 11(11):1745-52. PubMed ID: 10545478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MHC class II complexes sample intermediate states along the peptide exchange pathway.
    Wieczorek M; Sticht J; Stolzenberg S; Günther S; Wehmeyer C; El Habre Z; Álvaro-Benito M; Noé F; Freund C
    Nat Commun; 2016 Nov; 7():13224. PubMed ID: 27827392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TCR-mediated adhesion of T cell hybridomas to planar bilayers containing purified MHC class II/peptide complexes and receptor shedding during detachment.
    Dustin ML; Miller JM; Ranganath S; Vignali DA; Viner NJ; Nelson CA; Unanue ER
    J Immunol; 1996 Sep; 157(5):2014-21. PubMed ID: 8757322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cell receptor interaction with peptide/major histocompatibility complex (MHC) and superantigen/MHC ligands is dominated by antigen.
    Ehrich EW; Devaux B; Rock EP; Jorgensen JL; Davis MM; Chien YH
    J Exp Med; 1993 Aug; 178(2):713-22. PubMed ID: 8393480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional evidence for TCR-intrinsic specificity for MHCII.
    Parrish HL; Deshpande NR; Vasic J; Kuhns MS
    Proc Natl Acad Sci U S A; 2016 Mar; 113(11):3000-5. PubMed ID: 26831112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of bispecific heteroconjugated antibodies (anti-T cell antigen receptor x anti-MHC class II) to study activation of T cells with a full length or truncated antigen receptor zeta-chain.
    Wu S; Yang Y; Sadegh-Nasseri S; Ashwell JD
    J Immunol; 1993 Mar; 150(6):2211-21. PubMed ID: 8450208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterial proteins that mediate the association of a defined subset of T cell receptor:CD4 complexes with class II MHC.
    Yagi J; Baron J; Buxser S; Janeway CA
    J Immunol; 1990 Feb; 144(3):892-901. PubMed ID: 2136903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Class II MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition.
    Patel DM; Arnold PY; White GA; Nardella JP; Mannie MD
    J Immunol; 1999 Nov; 163(10):5201-10. PubMed ID: 10553040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent T cell activation with dimeric peptide-major histocompatibility complex class II ligand: the role of CD4 coreceptor.
    Hamad AR; O'Herrin SM; Lebowitz MS; Srikrishnan A; Bieler J; Schneck J; Pardoll D
    J Exp Med; 1998 Nov; 188(9):1633-40. PubMed ID: 9802975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coreceptor affinity for MHC defines peptide specificity requirements for TCR interaction with coagonist peptide-MHC.
    Hoerter JA; Brzostek J; Artyomov MN; Abel SM; Casas J; Rybakin V; Ampudia J; Lotz C; Connolly JM; Chakraborty AK; Gould KG; Gascoigne NR
    J Exp Med; 2013 Aug; 210(9):1807-21. PubMed ID: 23940257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Costimulation and endogenous MHC ligands contribute to T cell recognition.
    Wülfing C; Sumen C; Sjaastad MD; Wu LC; Dustin ML; Davis MM
    Nat Immunol; 2002 Jan; 3(1):42-7. PubMed ID: 11731799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure of an autoimmune T cell receptor complexed with class II peptide-MHC: insights into MHC bias and antigen specificity.
    Maynard J; Petersson K; Wilson DH; Adams EJ; Blondelle SE; Boulanger MJ; Wilson DB; Garcia KC
    Immunity; 2005 Jan; 22(1):81-92. PubMed ID: 15664161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide-major histocompatibility complex class II complexes with mixed agonist/antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent intracellular signaling.
    Racioppi L; Ronchese F; Matis LA; Germain RN
    J Exp Med; 1993 Apr; 177(4):1047-60. PubMed ID: 8384651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A DNA Origami-Based Biointerface to Interrogate the Spatial Requirements for Sensitized T-Cell Antigen Recognition.
    Hellmeier J; Platzer R; Huppa JB; Sevcsik E
    Methods Mol Biol; 2023; 2654():277-302. PubMed ID: 37106189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TCR signaling for initiation and completion of thymocyte positive selection has distinct requirements for ligand quality and presenting cell type.
    Yasutomo K; Lucas B; Germain RN
    J Immunol; 2000 Sep; 165(6):3015-22. PubMed ID: 10975810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Major histocompatibility complex (MHC) class II-peptide complexes arrive at the plasma membrane in cholesterol-rich microclusters.
    Bosch B; Heipertz EL; Drake JR; Roche PA
    J Biol Chem; 2013 May; 288(19):13236-42. PubMed ID: 23532855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.